Properties of gene delivery vehicles, including gene transfer e‹ciencies and toxicities, are a key parameter for successful gene therapy. Among various types of gene delivery vehicles that have been developed so far, adenovirus (Ad) vectors have promising potentials as a vector for gene therapy because they can easily be grown to high titers and can e‹ciently deliver genes to both dividing and non-dividing cells. However, recent studies demonstrated some drawbacks of conventional Ad vectors, which are composed of subgroup C Ad serotype 5 (Ad5). First, Ad5 vectors poorly transduce cells lacking the primary receptor for Ad5, coxsackievirus and adenovirus receptor (CAR). Second, majority of adults have neutralizing antibodies to Ad5. In order to overcome these drawbacks, we developed a novel Ad vector which is fully composed of subgroup B Ad serotype 35 (Ad35). Ad35 vectors can infect a variety of human cells because the primary receptor for Ad35, CD46, is ubiquitously expressed in human cells. Furthermore, Ad35 vectors e‹ciently transduce in the presence of anti-Ad5 antibodies, and seroprevalence of Ad35 in adults is much lower than that of Ad5. In the current review, I introduce our recent work on development and evaluation of Ad35 vectors, and I also discuss the potential of Ad35 vectors as gene delivery vehicles.
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Fig. 6. Transduction E‹ciencies of Ad35 Vectors in CHO Cells Expressing the CD46 Mutants
The cells were transduced with Ad35 vectors expressingˆre‰y luciferase at 3000 VP/cell for 1.5 h. Following a 48 h-incubation, the luciferase productions in the cells were measured by chemiluminescence assay. The data was normalized to the luciferase production in parental CHO cells. 
. Fire‰y Luciferase Production in CD46TG and Wild-type Mice following Intravenous and Intraperitoneal Injection of Ad35 Vectors
Fire‰y luciferase-expressing Ad35 vectors were intravenously or intraperitoneally injected at the dose of 1.5×10 10 VP/mouse. Forty-eight hours later, the organs were collected, and luciferase production was measured using a chemiluminescent assay. All data represent the mean±S.D. of 4 6 mice. The human CD34 ＋ cells were suspended in the medium containing the cytokine cocktail. The cells were infected with Ad5 or Ad35 vectors expressing enhanced green ‰uorescence protein (GFP) at 300 plaque forming unit (PFU)/cell 16 18 h after seeding. The culture medium was added 1.5 h after transduction. Following a 48 h-incubation, the cells were recovered and subjected to ‰ow cytometric analysis. 
